Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241279 · ClinicalTrials.gov registry record · Phase 4
Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses
A Phase 4 study, sponsored by Bausch & Lomb Incorporated.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT01241279 is a Phase 4 study that was terminated before completion, run by Bausch & Lomb Incorporated. The registered enrollment target is 6 participants.
The verdict
NCT01241279, a Phase 4 study, was terminated before completion, sponsored by Bausch & Lomb Incorporated.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the correlation of near vision and changes in higher order aberrations following lens extraction and to characterize the defocus curves of Crystalens® AO™ intraocular lens (IOL) versus the monofocal aspheric SofPort® LI61AO IOL in adults.
Interventions
- DEVICE Crystalens AO
- DEVICE SoftPort LI61AO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01241279
The ClinicalTrials.gov registry entry for NCT01241279 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Crystalens AO is the first listed.
NCT01241279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01241279 about?
NCT01241279 is a clinical study titled "Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses". The objective of this study is to demonstrate the correlation of near vision and changes in higher order aberrations following lens extraction and to characterize the defocus curves of Crystalens® AO™ intraocular lens (IOL) versus the monofocal aspheric SofPort® LI61AO IOL in adults.
What is the current status of trial NCT01241279?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2010-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01241279?
The interventions under investigation include: Crystalens AO (DEVICE), SoftPort LI61AO (DEVICE).
Who is sponsoring clinical trial NCT01241279?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.